Ropes Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.49M | Sell |
4,645
-736
| -14% | -$379K | 0.48% | 46 |
|
|
2023
Q2 | $2.52M | Buy |
5,381
+257
| +5% | +$108K | 0.42% | 58 |
|
|
2023
Q1 | $1.76M | Buy |
5,124
+678
| +15% | +$229K | 0.32% | 86 |
|
|
2022
Q4 | $1.63M | Buy |
4,446
+602
| +16% | +$213K | 0.29% | 84 |
|
|
2022
Q3 | $1.24M | Sell |
3,844
-109
| -3% | -$34.5K | 0.26% | 90 |
|
|
2022
Q2 | $1.28M | Sell |
3,953
-157
| -4% | -$47.1K | 0.26% | 95 |
|
|
2022
Q1 | $1.18M | Sell |
4,110
-853
| -17% | -$220K | 0.2% | 108 |
|
|
2021
Q4 | $1.37M | Sell |
4,963
-11
| -0.2% | -$2.79K | 0.24% | 92 |
|
|
2021
Q3 | $1.15M | Sell |
4,974
-517
| -9% | -$128K | 0.18% | 103 |
|
|
2021
Q2 | $1.26M | Buy |
5,491
+614
| +13% | +$123K | 0.2% | 99 |
|
|
2021
Q1 | $950K | Buy |
4,877
+391
| +9% | +$76.5K | 0.17% | 118 |
|
|
2020
Q4 | $757K | Sell |
4,486
-217
| -5% | -$32.4K | 0.12% | 120 |
|
|
2020
Q3 | $696K | Sell |
4,703
-136
| -3% | -$21K | 0.13% | 119 |
|
|
2020
Q2 | $794K | Sell |
4,839
-37
| -0.8% | -$5.68K | 0.16% | 103 |
|
|
2020
Q1 | $676K | Sell |
4,876
-260
| -5% | -$35.7K | 0.17% | 96 |
|
|
2019
Q4 | $675K | Hold |
5,136
| – | – | 0.15% | 116 |
|
|
2019
Q3 | $574K | Sell |
5,136
-15
| -0.3% | -$1.67K | 0.12% | 131 |
|
|
2019
Q2 | $571K | Sell |
5,151
-15
| -0.3% | -$1.77K | 0.12% | 132 |
|
|
2019
Q1 | $670K | Sell |
5,166
-171
| -3% | -$20.8K | 0.18% | 114 |
|
|
2018
Q4 | $618K | Sell |
5,337
-239
| -4% | -$26.7K | 0.18% | 115 |
|
|
2018
Q3 | $598K | Hold |
5,576
| – | – | 0.15% | 130 |
|
|
2018
Q2 | $476K | Hold |
5,576
| – | – | 0.13% | 141 |
|
|
2018
Q1 | $431K | Hold |
5,576
| – | – | 0.12% | 147 |
|
|
2017
Q4 | $471K | Hold |
5,576
| – | – | 0.12% | 144 |
|
|
2017
Q3 | $477K | Sell |
5,576
-196
| -3% | -$16.1K | 0.13% | 143 |
|
|
2017
Q2 | $475K | Sell |
5,772
-110
| -2% | -$8.97K | 0.13% | 136 |
|
|
2017
Q1 | $495K | Buy |
5,882
+10
| +0.2% | +$801 | 0.14% | 138 |
|
|
2016
Q4 | $432K | Buy |
5,872
+813
| +16% | +$60.5K | 0.14% | 133 |
|
|
2016
Q3 | $406K | Buy |
5,059
+137
| +3% | +$11K | 0.14% | 131 |
|
|
2016
Q2 | $388K | Sell |
4,922
-28
| -0.6% | -$2.11K | 0.14% | 131 |
|
|
2016
Q1 | $356K | Buy |
4,950
+1,437
| +41% | +$109K | 0.16% | 109 |
|
|
2015
Q4 | $296K | Sell |
3,513
-2,635
| -43% | -$219K | 0.13% | 127 |
|
|
2015
Q3 | $515K | Buy |
6,148
+3,046
| +98% | +$257K | 0.27% | 67 |
|
|
2015
Q2 | $259K | Sell |
3,102
-2,392
| -44% | -$182K | 0.14% | 110 |
|
|
2015
Q1 | $399K | Buy |
+5,494
| New | +$391K | 0.21% | 84 |
|
Other funds holding LLY
Ropes Wealth Advisors's LLY Position: Q3 2023 in Review
Ropes Wealth Advisors reduced its Eli Lilly (LLY) stake by 14% in Q3 2023, selling an estimated $379K and leaving 4,645 shares worth $2.49M. The position accounts for 0.48% of the portfolio, ranked #46.
Ropes Wealth Advisors first reported a position in LLY in Q1 2015 and has held it in 35 quarters since. The position peaked at $2.52M in Q2 2023. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Ropes Wealth Advisors held 4,645 shares of Eli Lilly worth $2.49M as of Q3 2023.
- Ropes Wealth Advisors sold 736 Eli Lilly shares in Q3 2023, an estimated $379K.
- Eli Lilly made up 0.48% of Ropes Wealth Advisors's portfolio in Q3 2023, its #46 holding.
- Ropes Wealth Advisors first reported a position in Eli Lilly in Q1 2015 and has held it in 35 quarters since.
- Ropes Wealth Advisors's Eli Lilly position peaked at $2.52M in Q2 2023.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.